C

China National Medicines Corp Ltd
SSE:600511

Watchlist Manager
China National Medicines Corp Ltd
SSE:600511
Watchlist
Price: 34.38 CNY -0.12% Market Closed
Market Cap: 25.9B CNY
Have any thoughts about
China National Medicines Corp Ltd?
Write Note

China National Medicines Corp Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

China National Medicines Corp Ltd
Total Equity Peer Comparison

Comparables:
1099
601607
600998
000963
Q
301015

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
C
China National Medicines Corp Ltd
SSE:600511
Total Equity
ÂĄ16.1B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
22%
Sinopharm Group Co Ltd
HKEX:1099
Total Equity
ÂĄ69.6B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
12%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Total Equity
ÂĄ68.5B
CAGR 3-Years
13%
CAGR 5-Years
11%
CAGR 10-Years
10%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Total Equity
ÂĄ24.3B
CAGR 3-Years
2%
CAGR 5-Years
6%
CAGR 10-Years
13%
Huadong Medicine Co Ltd
SZSE:000963
Total Equity
ÂĄ21.8B
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
23%
Q
Qingdao Baheal Medical Inc
SZSE:301015
Total Equity
ÂĄ2.7B
CAGR 3-Years
22%
CAGR 5-Years
20%
CAGR 10-Years
N/A

See Also

What is China National Medicines Corp Ltd's Total Equity?
Total Equity
16.1B CNY

Based on the financial report for Jun 30, 2024, China National Medicines Corp Ltd's Total Equity amounts to 16.1B CNY.

What is China National Medicines Corp Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
22%

Over the last year, the Total Equity growth was 10%. The average annual Total Equity growth rates for China National Medicines Corp Ltd have been 11% over the past three years , 11% over the past five years , and 22% over the past ten years .

Back to Top